HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex

The development of boron agents with integrated functionality, including biocompatibility, high boron content, and cancer cell targeting, is desired to exploit the therapeutic efficacy of boron neutron capture therapy (BNCT). Here, we report the therapeutic efficacy of BNCT using a HER-2-targeted an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamana, Keita, Kawasaki, Riku, Kondo, Kousuke, Hirano, Hidetoshi, Kawamura, Shogo, Sanada, Yu, Bando, Kaori, Tabata, Anri, Azuma, Hideki, Takata, Takushi, Sakurai, Yoshinori, Tanaka, Hiroki, Kodama, Tomoki, Kawamoto, Seiji, Nagasaki, Takeshi, Ikeda, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2023
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367957/
https://www.ncbi.nlm.nih.gov/pubmed/37496630
http://dx.doi.org/10.1039/d3na00028a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367957/
https://www.ncbi.nlm.nih.gov/pubmed/37496630
http://dx.doi.org/10.1039/d3na00028a

Ejemplares similares